Patients with obesity and substance use disorders
Fluoroquinolones (ciprofloxacin, levofloxacin) and macrolides (azithromycin) are most sensitive to absorption delays from semaglutide's gastric effects
Life after bariatric surgery After bariatric surgery, your eating habits, digestion, and energy levels will change
Some key patterns from clinical research and patient reports: Musculoskeletal effects tend to be dose-dependent across all medications Side effects typically emerge during dose escalation periods Most symptoms improve over time with continued treatment Management strategies (hydration, electrolytes, etc.) are similar across all GLP-1 medications The benefit-risk profile for each medication should be discussed with your healthcare provider, considering your specific health needs, weight loss goals, and side effect concerns
While Semaglutide might cause gastrointestinal issues, alternatives like liraglutide may cause similar effects, whereas orlistat is known for causing fatty stools
Individualized Dosing with GLP-1 ID While the STEP and SURMOUNT trials used fixed-dose protocols with branded medications, Ivim Healths GLP-1 ID (Individualized Dosing) program uses compounded semaglutide and tirzepatide formulations to allow for more flexible, patient-specific dosing